Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Cetrelimab |
Trade Name | |
Synonyms | JNJ63723283|JNJ 63723283|JNJ-63723283 |
Drug Descriptions |
Cetrelimab (JNJ-63723283) is a monoclonal antibody that targets PD-1 (PDCD1) and inhibits binding of the PD-L1 (CD274) ligand, potentially resulting in enhanced anti-tumor immune response (PMID: 28943093). |
DrugClasses | Immune Checkpoint Inhibitor 150 PD-L1/PD-1 antibody 131 |
CAS Registry Number | 2050478-92-5 |
NCIT ID | C129448 |